Kindred Healthcare (KND) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Kindred Healthcare (KND) PT Raised to $13 at Barclays Following 1Q Report; 'Solid Start to '17, Significant Potential Value to Come'
May 5, 2017 3:17 PM EDTBarclays raised its price target on Kindred Healthcare (NYSE: KND) to $13.00 (from $11.00) while maintaining a Overweight rating, following the company's first quarter.
Analyst Joshua Raskin notes the company provided in-line earnings per share results, but revenue figures below the Street, as the focus... More
